Colossal Biosciences and Anduril's Palmer Luckey back Warhound, a startup developing genetically engineered dogs for military work.
Warhound emerged from stealth on October 22 with $200 million in seed funding and a $1.2 billion post-money valuation, TechCrunch reported. The startup wants to develop genetically enhanced dogs...
Warhound raised $200 million to develop gene-edited military dogs and build the kennels and training facilities needed to prepare them for service.
Warhound plans to bring together biotechnology associated with Colossal Biosciences and defence technology developed by Anduril to establish a domestic supply of working dogs in the US.
The company is a collab between defense tech firm Anduril and Colossal Biosciences, the biotech startup looking to bring back the woolly mammoth.
An Anduril-backed venture aims to genetically engineer faster and sharper-nosed military dogs to help beat the enemy.
First reported:
First saved on ClustZ:
Coverage updated:
We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.